Test Bank - Lilley’s Pharmacology for Canadian Health Care Practice, 5th Ed.
By Kara Sealock, Cydnee Seneviratne
(All Chapters 1-58, Latest Edition, Verified Answers with Rationales)
, TABLE OF CONTENTS 32. Thyroid and Antithyroid Drugs
33. Antidiabetic Drugs
PART 1: Pharmacology Basics 34. Adrenal Drugs
35. Women's Health Drugs
1. Nursing Practice in Canada and Drug Therapy 36. Men's Health Drugs
2. Pharmacological Principles
3. Legal and Ethical Considerations PART 6: Drugs Affecting the Respiratory
4. Patient-Focused Considerations System
5. Gene Therapy and Pharmacogenomics 37. Antihistamines Expectorants
6. Medication Errors: Preventing and Responding 38. Respiratory Drugs
7. Patient Education and Drug Therapy
8. Over-the-Counter Drugs and Natural Health PART 7: Drugs Affecting the Gastrointestinal
Products System and Nutrition
9. Vitamins and Minerals 39. Acid-Controlling Drugs
10. Principles of Drug Administration 40. Antidiarrheal Drugs and Laxatives
41. Antiemetic and Antinausea Drugs
PART 2: Drugs Affecting the Central Nervous 42. Nutritional Supplements
System
11. Analgesic Drugs PART 8: Anti-Infective and Anti-Inflammatory
12. General and Local Anaesthetics Drugs
13. Central Nervous System Depressants and 43. Antibiotics Part 1: Sulfonamides, Penicillins,
Muscle Relaxants Cephalosporins, Macrolides, and Tetracyclines
14. Central Nervous System Stimulants and Related 44. Antibiotics Part 2: Aminoglycosides,
Drugs Fluoroquinolones, and Other Drugs
15. Antiepileptic Drugs 45. Antiviral Drugs
16. Antiparkinsonian Drugs 46. Antitubercular Drugs
17. Psychotherapeutic Drugs 47. Antifungal Drugs
18. Substance Use Disorder 48. Antimalarial, Antiprotozoal, and Anthelmintic
Drugs
PART 3: Drugs Affecting the Autonomic 49. Anti-Inflammatory and Antigout Drugs
Nervous System
19. Adrenergic Drugs PART 9: Immune and Biological Modifiers and
20. Adrenergic-Blocking Drugs Chemotherapeutic Drugs
21. Cholinergic Drugs 50. Immunosuppressant Drugs
22. Cholinergic-Blocking Drugs 51. Immunizing Drugs and Pandemic Preparedness
52. Antineoplastic Drugs Part 1: Cancer Overview
PART 4: Drugs Affecting the Cardiovascular and Cell Cycle–Specific Drugs
and Renal System 53. Antineoplastic Drugs Part 2: Cell Cycle–
23. Antihypertensive Drugs Nonspecific and Miscellaneous Drugs
24. Antianginal Drugs 54. Biological Response–Modifying Drugs and
25. Heart Failure Drugs Antirheumatic Drugs
26. Diuretic Drugs
27. Antidysrhythmic Drugs PART 10: Miscellaneous Therapeutics:
28. Coagulation Modifier Drugs Hematological, Ophthalmic, and Otic Drugs
29. Antilipemic Drugs 55. Anemia Drugs
30. Fluids and Electrolytes 56. Dermatological Drugs
57. Ophthalmic Drugs
PART 5: Drugs Affecting the Endocrine System 58. Otic Drugs
31. Pituitary Drugs
,Chapter 01: Nursing Practice in Canada and Drug Therapy
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
Answer: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about how a patient
respond to heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to swallow, he
cannot take medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
Answer: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the prescriber. This is
not a “right time” problem because the ordered frequency has not changed. This is not a “right dose” problem because the
dose is not related to an inability to swallow. This is not a “right medication” problem because the medication ordered will
not change, just the route.
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and has been
documenting signs of possible adverse effects. What nursing process phase is the nurse practicing?
a. Planning
, b. Evaluation
c. Implementation
d. Nursing diagnosis
Answer: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing diagnosis are not
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which statement
best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
Answer: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable outcome criterion.
Following instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatment
regimen is not objective and would be difficult to measure.
DIF: Cognitive Level: Application
5. Which activity best reflects the implementation phase of the nursing process for the patient who is newly
diagnosed with type 1 diabetes mellitus?
a. Providing education regarding self-injection technique
b. Setting goals and outcome criteria with the patient’s input
c. Recording a history of over-the-counter medications used at home
d. Formulating nursing diagnoses regarding knowledge deficits related to the new treatment regimen
Answer: A
By Kara Sealock, Cydnee Seneviratne
(All Chapters 1-58, Latest Edition, Verified Answers with Rationales)
, TABLE OF CONTENTS 32. Thyroid and Antithyroid Drugs
33. Antidiabetic Drugs
PART 1: Pharmacology Basics 34. Adrenal Drugs
35. Women's Health Drugs
1. Nursing Practice in Canada and Drug Therapy 36. Men's Health Drugs
2. Pharmacological Principles
3. Legal and Ethical Considerations PART 6: Drugs Affecting the Respiratory
4. Patient-Focused Considerations System
5. Gene Therapy and Pharmacogenomics 37. Antihistamines Expectorants
6. Medication Errors: Preventing and Responding 38. Respiratory Drugs
7. Patient Education and Drug Therapy
8. Over-the-Counter Drugs and Natural Health PART 7: Drugs Affecting the Gastrointestinal
Products System and Nutrition
9. Vitamins and Minerals 39. Acid-Controlling Drugs
10. Principles of Drug Administration 40. Antidiarrheal Drugs and Laxatives
41. Antiemetic and Antinausea Drugs
PART 2: Drugs Affecting the Central Nervous 42. Nutritional Supplements
System
11. Analgesic Drugs PART 8: Anti-Infective and Anti-Inflammatory
12. General and Local Anaesthetics Drugs
13. Central Nervous System Depressants and 43. Antibiotics Part 1: Sulfonamides, Penicillins,
Muscle Relaxants Cephalosporins, Macrolides, and Tetracyclines
14. Central Nervous System Stimulants and Related 44. Antibiotics Part 2: Aminoglycosides,
Drugs Fluoroquinolones, and Other Drugs
15. Antiepileptic Drugs 45. Antiviral Drugs
16. Antiparkinsonian Drugs 46. Antitubercular Drugs
17. Psychotherapeutic Drugs 47. Antifungal Drugs
18. Substance Use Disorder 48. Antimalarial, Antiprotozoal, and Anthelmintic
Drugs
PART 3: Drugs Affecting the Autonomic 49. Anti-Inflammatory and Antigout Drugs
Nervous System
19. Adrenergic Drugs PART 9: Immune and Biological Modifiers and
20. Adrenergic-Blocking Drugs Chemotherapeutic Drugs
21. Cholinergic Drugs 50. Immunosuppressant Drugs
22. Cholinergic-Blocking Drugs 51. Immunizing Drugs and Pandemic Preparedness
52. Antineoplastic Drugs Part 1: Cancer Overview
PART 4: Drugs Affecting the Cardiovascular and Cell Cycle–Specific Drugs
and Renal System 53. Antineoplastic Drugs Part 2: Cell Cycle–
23. Antihypertensive Drugs Nonspecific and Miscellaneous Drugs
24. Antianginal Drugs 54. Biological Response–Modifying Drugs and
25. Heart Failure Drugs Antirheumatic Drugs
26. Diuretic Drugs
27. Antidysrhythmic Drugs PART 10: Miscellaneous Therapeutics:
28. Coagulation Modifier Drugs Hematological, Ophthalmic, and Otic Drugs
29. Antilipemic Drugs 55. Anemia Drugs
30. Fluids and Electrolytes 56. Dermatological Drugs
57. Ophthalmic Drugs
PART 5: Drugs Affecting the Endocrine System 58. Otic Drugs
31. Pituitary Drugs
,Chapter 01: Nursing Practice in Canada and Drug Therapy
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
Answer: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about how a patient
respond to heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to swallow, he
cannot take medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
Answer: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the prescriber. This is
not a “right time” problem because the ordered frequency has not changed. This is not a “right dose” problem because the
dose is not related to an inability to swallow. This is not a “right medication” problem because the medication ordered will
not change, just the route.
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and has been
documenting signs of possible adverse effects. What nursing process phase is the nurse practicing?
a. Planning
, b. Evaluation
c. Implementation
d. Nursing diagnosis
Answer: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing diagnosis are not
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which statement
best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
Answer: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable outcome criterion.
Following instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatment
regimen is not objective and would be difficult to measure.
DIF: Cognitive Level: Application
5. Which activity best reflects the implementation phase of the nursing process for the patient who is newly
diagnosed with type 1 diabetes mellitus?
a. Providing education regarding self-injection technique
b. Setting goals and outcome criteria with the patient’s input
c. Recording a history of over-the-counter medications used at home
d. Formulating nursing diagnoses regarding knowledge deficits related to the new treatment regimen
Answer: A
